Skip to main content

and
  1. Article

    Open Access

    Benefits for children with suspected cancer from routine whole-genome sequencing

    Clinical whole-genome sequencing (WGS) has been shown to deliver potential benefits to children with cancer and to alter treatment in high-risk patient groups. It remains unknown whether offering WGS to every ...

    Angus Hodder, Sarah M. Leiter, Jonathan Kennedy, Dilys Addy in Nature Medicine (2024)

  2. No Access

    Article

    Advancing diagnosis and research for rare genetic diseases in Indigenous peoples

    Achieving a diagnosis for Indigenous people living with a rare, often genetic, disease is crucial for equitable healthcare. The International Rare Disease Research Consortium convened a global Task Force to br...

    Gareth Baynam, Daria Julkowska, Sarah Bowdin, Azure Hermes in Nature Genetics (2024)

  3. No Access

    Article

    A call for global action for rare diseases in Africa

    The 11th International Conference on Rare Diseases and Orphan Drugs (ICORD), South Africa, included the Africa-Rare initiative launch and facilitated multi-stakeholder engagement in the challenges facing, and opp...

    Gareth S. Baynam, Stephen Groft, Francois H. van der Westhuizen in Nature Genetics (2020)

  4. Article

    Open Access

    Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children

    With growing evidence that rare single gene disorders present in the neonatal period, there is a need for rapid, systematic, and comprehensive genomic diagnoses in ICUs to assist acute and long-term clinical d...

    Courtney E. French, Isabelle Delon, Helen Dolling in Intensive Care Medicine (2019)

  5. Article

    Open Access

    Genome sequencing as a platform for pharmacogenetic genoty**: a pediatric cohort study

    Whole-genome sequencing and whole-exome sequencing have proven valuable for diagnosing inherited diseases, particularly in children. However, usage of sequencing data as a pharmacogenetic screening tool to ens...

    Iris Cohn, Tara A. Paton, Christian R. Marshall, Raveen Basran in npj Genomic Medicine (2017)

  6. Article

    Open Access

    Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine

    The standard of care for first-tier clinical investigation of the aetiology of congenital malformations and neurodevelopmental disorders is chromosome microarray analysis (CMA) for copy-number variations (CNVs...

    Dimitri J Stavropoulos, Daniele Merico, Rebekah Jobling in npj Genomic Medicine (2016)

  7. Article

    Open Access

    Novel MASP1 mutations are associated with an expanded phenotype in 3MC1 syndrome

    3MC1 syndrome is a rare autosomal recessive disorder characterized by intellectual disability, short stature and distinct craniofacial, umbilical, and sacral anomalies. Five mutations in MASP1, encoding lectin co...

    Tahir Atik, Asuman Koparir, Guney Bademci in Orphanet Journal of Rare Diseases (2015)

  8. No Access

    Chapter

    Danon Disease Due to a Novel LAMP2 Microduplication

    Danon disease is a rare X-linked disorder comprising hypertrophic cardiomyopathy, skeletal myopathy, intellectual disability, and retinopathy; mutations of the lysosome-associated membrane protein gene LAMP2 are ...

    Matthew A. Lines, Stacy Hewson, William Halliday in JIMD Reports, Volume 14 (2014)